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Abstract
C13H10F3N3O4, triclinic, P1̄ (no. 2), a= 7.0524(14) Å,
b= 7.8044(16) Å, c= 12.954(3) Å, α= 97.93(3)°, β= 96.29(3)°,
γ = 100.11(3)°, V = 688.6(3) Å3, Z = 2, Rgt(F)=0.0478,
wRref(F2)=0.1140, T = 200 K.
CCDC no.: 1542451
The asymmetric unit of the title crystal structure is shown in
the figure. Tables 1 and 2 contain details of the measurement
method and a list of the atoms including atomic coordinates
and displacement parameters.
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Table 1: Data collection and handling.
Crystal: Colourless prism
Size: 0.25×0.20×0.15 mm
Wavelength: Mo Kα radiation (0.71073 Å)
µ: 1.4 cm−1
Diffractometer, scan mode: Nonius KappCCD, φ and ω
2θmax, completeness: 61°, 98.4%
N(hkl)measured, N(hkl)unique, Rint: 7772, 4105, 0.031
Criterion for Iobs, N(hkl)gt: Iobs > 2 σ(Iobs), 2579
N(param)refined: 210
Programs: Nonius programs [1], SHELX [2]
Source of material
Ethyl 1-(4-nitrophenyl)-5-(trifluoromethyl)-1H-pyrazole-4-
carboxylate was purchased from Sigma-Aldrich. Crystals
suitable for the X-ray diffraction experiments were obtained
by recrystallization from methanol.
Experimental details
The hydrogen atoms were placed at geometrically idealized
positions with C—H distances set to 0.93, 0.97 and 0.96 Å
fromphenyl,methylene andmethyl C atoms, respectively. The
isotropic displacement parameters were set equal to 1.2Ueq
and 1.5Ueq of the parent C atoms.
Comment
Pyrazole derivatives have broad applications in medicinal
[3, 4] and agricultural chemistry [5, 6]. The pharmacological
activity of these compounds is very diverse. A number of sub-
stituted pyrazoles are reported as anti-inflammatory, anal-
gesic, anti-bacterial and anti-cancer agents [3, 4]. It has been
found that the presence of a fluoroalkyl substituent on the
pyrazole core can significantly increase the lipophilicity and
solubility of the compounds and thus improve their biologi-
cal activity [7–9]. The fluoroalkylated pyrazoles are therefore
promising drug andherbicide candidates,while someof them
alreadyfindpractical use, as is the casewith thenon-steroidal
antirheumatic drug celecoxib [10], or a broad-use insecticide
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Table 2: Fractional atomic coordinates and isotropic or equivalent
isotropic displacement parameters (Å2).
Atom x y z Uiso*/Ueq
F1 0.23950(16) 0.24478(14) 0.13371(8) 0.0545(3)
F2 0.11903(14) −0.01258(15) 0.16293(9) 0.0621(3)
F3 0.30087(16) 0.01796(16) 0.04237(8) 0.0595(3)
O1 0.27285(19) 0.94909(14) 0.42622(10) 0.0487(3)
O2 0.00370(17) 0.77231(15) 0.43368(10) 0.0476(3)
O3 0.41696(18) −0.27728(16) 0.09840(11) 0.0572(4)
O4 0.72997(15) −0.25769(13) 0.16326(8) 0.0358(3)
N1 0.52381(16) 0.22554(15) 0.29754(9) 0.0272(3)
N2 0.69502(17) 0.20633(16) 0.34964(10) 0.0313(3)
N3 0.17602(19) 0.80098(16) 0.42229(10) 0.0331(3)
C1 0.4379(2) 0.37065(17) 0.33726(11) 0.0261(3)
C2 0.5517(2) 0.53877(19) 0.35806(11) 0.0301(3)
H2 0.6829 0.5562 0.3503 0.036*
C3 0.4665(2) 0.68038(18) 0.39055(11) 0.0306(3)
H3 0.5397 0.7944 0.4055 0.037*
C4 0.2712(2) 0.64932(18) 0.40030(11) 0.0267(3)
C5 0.1603(2) 0.48161(18) 0.38674(11) 0.0280(3)
H5 0.0308 0.4640 0.3981 0.034*
C6 0.2464(2) 0.34017(18) 0.35583(11) 0.0293(3)
H6 0.1760 0.2255 0.3476 0.035*
C7 0.7300(2) 0.05689(19) 0.30129(12) 0.0311(3)
H7 0.8388 0.0102 0.3205 0.037*
C8 0.5840(2) −0.02324(18) 0.21749(11) 0.0295(3)
C9 0.4537(2) 0.08995(18) 0.21664(11) 0.0285(3)
C10 0.2778(2) 0.0844(2) 0.13885(12) 0.0389(4)
C11 0.5641(2) −0.1974(2) 0.15184(12) 0.0342(3)
C12 0.7245(3) −0.4309(2) 0.10223(13) 0.0405(4)
H12A 0.7097 −0.4243 0.0276 0.049*
H12B 0.6152 −0.5151 0.1158 0.049*
C13 0.9094(3) −0.4879(3) 0.13379(16) 0.0586(5)
H13A 1.0166 −0.4045 0.1194 0.088*
H13B 0.9084 −0.6019 0.0947 0.088*
H13C 0.9228 −0.4940 0.2077 0.088*
fipronil [11], both belonging to N-phenylpyrazoles. As a part
of our ongoing interest on the synthesis, physico-chemical
and structural properties of the pyrazole based coordination
compounds [12, 13] we examined the crystal structure of the
title pyrazole ligand.
The bond lengths and angles within the N-
phenylpyrazole core are comparable with those reported
for the similar pyrazole ligands [14–18]. The C1—N1 bond
[1.436(2) Å] allows a rotation of the phenyl relative to
the pyrazole ring, thus the dihedral angle between the
corresponding ring planes is 49.26(6)°. In similar N-
phenylpyrazole derivatives this dihedral angle varies in
a broad range from 44.8 to 88.9° [15]. The torsion angle
C5—C4—N3—O1 of 4.1(2)°, indicates only a slight twisting
of the attached nitro group with respect to the phenyl
ring. The carbon atom of the pyrazole CF3 substituent
(C10) slightly deviates from the plane of the pyrazole ring
[0.14(1) Å]. Inspection of the deviation of F atoms in different
fluoromethyl pyrazoles [14, 15] indicates that the CF3 group
can rotate with respect to the pyrazole ring. Thus the
displacement of the F1 (chosen as the least deviating from
the pyrazole plane) can vary from 0.01 in [15, 16] to 0.7 Å
in the present case. The ethyl carboxylate group of the title
compound is essentially planar (r.m.s deviation of non-H
atoms is 0.05), with the maximum deviation of the terminal
C13 atom [0.061(1) Å]. The dihedral angle between the best
planes of the pyrazolyl fragment and ethyl carboxylate
groups is 13.7(1)°. In the crystal packing, the inversion-related
molecules form C–H· · ·O hydrogen-bonded dimers, using
the pairs of donors and acceptors from the ethyl carboxylate
group [C12—H12a· · ·O3i: C—H0.97 Å, C· · ·O3.152(2) Å,H· · ·O
2.60 Å, C—H· · ·O 116°, (i) −x+ 1, −y− 1, −z]. The structure
is further stabilized by weak C—H· · ·O interactions [C2—
H2· · ·O2ii: C—H 0.93 Å, C· · ·O 3.350(2) Å, H· · ·O 2.60 Å,
C—H· · ·O138° (ii) x+ 1,+y,+z], andweak π· · · π interactions
between the neighboring phenyl rings [Cg· · ·Cgiii 3.746 Å (iii)
−x+ 1, −y+ 1, −z+ 1].
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